Published 1992 | Version v1
Book

Myocardial perfusion imaging with copper-62 labeled Cu-PTSM. Chapter 13

Creators

  • 1. Purdue University, Lafayette (United States). Division of Nuclear Pharmacy

Description

The value of positron emission tomography (PET) in the study of myocardial physiology and clinical diagnosis of cardiac disease is widely recognized. The short-lived radionuclides most commonly used as labels for PET radiopharmaceuticals are 15O, 13N, 11C and 18F. These have proven particularly useful because they allow natural biochemical substrates to be labeled by isotopic substitution for tracer studies of a diversity of discrete physiological processes. Unfortunately, the short half-lives of these radionuclides (2, 10, 20, and 110 minutes, respectively) pose problems with regard to isotope production and delivery. Hospitals that employ 15O, 13N, 11C and 18F radiopharmaceuticals will generally find it necessary to operate an in-house cyclotron facility for radionuclide production, since only one 18F is sufficiently long-lived to allow remote production for distribution via a regional delivery system. For many hospitals, the expense of operating a cyclotron for radionuclide production presents a barrier to the use of PET in clinical diagnosis. (author). 30 refs., 3 figs., 3 tabs

Part of:
What's new in cardiac imaging?

Additional details

Publishing Information

Publisher
Kluwer Academic Publishers.
Imprint Place
Dordrecht (Netherlands)
ISBN
0-7923-1615-0
Imprint Title
What's new in cardiac imaging?
Imprint Pagination
564 p.
Journal Volume
133
Series
Developments in Cardiovascular Medicine.
Journal Page Range
p. 165-177.

Optional Information

Notes
Imprint:Includes subject index.